Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 228-958-7 | CAS number: 6379-72-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From January 19 to June 08, 2015
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 015
- Report date:
- 2015
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: ICH (2011) EMA/CHMP/ICH/126642/2008. Guideline S2(R1): Guidance on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use
- Deviations:
- no
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- UK GLP Compliance Programme (inspected on February 05-07, 2014/ signed on April 24, 2014)
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- 4-trans-propenylveratrole
- EC Number:
- 228-958-7
- EC Name:
- 4-trans-propenylveratrole
- Cas Number:
- 6379-72-2
- Molecular formula:
- C11H14O2
- IUPAC Name:
- (E)-1,2-Dimethoxy-4-prop-1-en-1-ylbenzene
- Test material form:
- liquid
- Details on test material:
- - Physical state: Pale yellow, oily liquid
- Storage condition of test material: Room temperature
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Crl:CD(SD)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (UK) Ltd.
- Age at study initiation: 71 to 78 days
- Weight at study initiation: 331-393 g for males; 225-276 g for females
- Housing: Pre-pairing - 5/sex/cage; Pairing – 1 male:1 female per cage; Males after mating – 5 males/cage; Gestation – 1 female /cage; Lactation – 1 female/cage (+ litter); Solid (polycarbonate) bottom cages were used during the acclimatisation, gestation, littering and lactation periods; Grid bottomed cages were used during pairing.
- Diet: SDS VRF1 Certified powdered diet, ad libitum
- Water: Potable water taken from the public supply, ad libitum
- Acclimation period: 6 days
ENVIRONMENTAL CONDITIONS
- Temperature: 19-23 °C
- Humidity: 40-70 %
- Air changes: Filtered fresh air which was passed to atmosphere and not recirculated.
- Photoperiod: 12 h dark / 12 h light
IN-LIFE DATES: From January 19 to June 08, 2015
Administration / exposure
- Route of administration:
- oral: feed
- Details on exposure:
- DIET PREPARATION
- Method of preparation: On each occasion of the preparation of the premix, the required amount of test substance was added to an equal amount of plain diet and stirred until visibly homogenous. This doubling up process was repeated until half of the final weight of premix was achieved. This mixture was then ground using a mechanical grinder after which it was made up to the final weight of the premix with plain diet. This premix was mixed in a Turbula mixer for 200 cycles to ensure the test substance was dispersed in the diet.
Aliquots of the premix were then diluted with further quantities of plain diet to produce the required dietary concentrations. Each batch of treated diet was mixed for a further 200 cycles in a Turbula mixer.
- Frequency of preparation: Weekly
- Storage of formulation: Ambient temperature. - Duration of treatment / exposure:
- Males were treated for a minimum of four consecutive weeks, including two weeks prior to pairing.
Females were treated for two weeks prior to pairing, throughout mating and gestation and until Day 7 of lactation. - Frequency of treatment:
- Continuously
- Post exposure period:
- None
Doses / concentrationsopen allclose all
- Dose / conc.:
- 1 500 ppm (nominal)
- Dose / conc.:
- 4 500 ppm (nominal)
- Dose / conc.:
- 15 000 ppm (nominal)
- No. of animals per sex per dose:
- Samples of one femur were taken at necropsy from five male and female animals per group.
- Control animals:
- yes, plain diet
- Positive control(s):
- - Positive control: Cyclophosphamide
- Doses / concentrations: 20 mg/kg bw
- Route of administration: Oral
Examinations
- Tissues and cell types examined:
- Coded slides were examined by fluorescence microscopy and 4000 polychromatic erythrocytes per animal were examined for the presence of micronuclei. At least one smear was examined per animal, any remaining smears being held temporarily in reserve in case of technical problems with the first smear.
The proportion of polychromatic erythrocytes was assessed by examination of a total of at least 1000 erythrocytes per animal and the number of micronucleated normochromatic erythrocytes was recorded. - Details of tissue and slide preparation:
- DETAILS OF SLIDE PREPARATION:
- The animals were killed by exposure to rising levels of carbon dioxide and one femur dissected out from each animal. The femurs were cleaned of all excess tissue and blood and the proximal epiphysis removed from each bone. The bone marrow of one femur from each animal was flushed out and pooled in a total volume of 3 mL of filtered foetal calf serum by aspiration. The resulting cell suspensions were centrifuged at 1000 rpm (150 x g) for 5 minutes and the supernatant discarded. The final cell pellet was resuspended in a small volume of foetal calf serum to facilitate smearing in the conventional manner on glass microscope slides (Schmid 1976).
FIXATION AND SLIDE STAINING
1. Fixed for a minimum of 10 minutes in methanol and allowed to air-dry
2. Rinsed in purified water
3. Stained in acridine orange solution (0.0125 mg/mL using purified water) for 4 minutes
4. Washed in purified water for 5 minutes
5. Rinsed in cold tap water for 2 minutes
6. Stored at room temperature until required
7. Immediately prior to scoring, slides are wet mounted with coverslips using purified water - Evaluation criteria:
- See section “Any other information on materials and methods incl. tables”
- Statistics:
- Each sex was analysed separately.
For the proportion of polychromatic erythrocytes, an asymptotic one-tailed Jonckheere’s test for trend (Jonckheere 1954) with “step-down” was used on Groups 1 to 4 for a decrease from control. If significant, then the analysis was carried out on Groups 1 to 3. Exact one-tailed Wilcoxon pairwise tests (Wilcoxon 1945), for a decrease from control, were also carried out on Group 1 (control) versus Groups 2, 3, 4 and 5.
For incidences of micronucleated polychromatic erythrocytes, an exact one-tailed Linear-by-Linear association test (Cytel 1995) with “step-down” was used on Groups 1 to 4 for an increase from control. If significant, then the analysis was carried out on Groups 1 to 3. Exact one-tailed pairwise Permutation tests (Cytel 1995), for an increase from control, were also carried out on Group 1 (control) versus Groups 2, 3, 4 and 5.
If the exact version of a test could not be calculated (due to the amount of data), then the asymptotic version was used instead.
Statistical significance was declared at the 5% level for all tests.
The data were received in an Excel document and analysed using SAS 9.1.3 (SAS Institute Inc., 2002) (Jonckheere's and Wilcoxon tests) and StatXact 3 (Cytel 1995) (Linear-by-Linear and Permutation tests).
Results and discussion
Test results
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- - Test item did not cause any statistically significant increases in the number of micronucleated polychromatic erythrocytes (MPCE) or micronucleated normochromatic erythrocytes (MNCE) in male or female rats.
- Proportion of polychromatic erythrocytes (%PCE): Test item did not cause any statistically significant decreases in the proportion of polychromatic erythrocytes in male or female rats.
- Positive control: The coded positive control slides prepared from study HLS1035 demonstrated the ability of the scorer to detect increases in micronucleated polychromatic erythrocytes.
Any other information on results incl. tables
Table 7.6.2/1: Summary of results and statistical analysis
Treatment |
Dosage |
Proportion of PCE % # (SD) |
Incidence MPCE mean # (SD) |
Group mean % MPCE # |
Male data |
||||
Vehicle |
0 |
49.5 (3.5) |
5.6 (1.7) |
0.14 |
Test item |
1500 ppm |
49.6 (2.9) |
7.0 (2.9) |
0.18 |
4500 ppm |
49.6 (2.3) |
4.8 (3.1) |
0.12 |
|
15000 ppm |
48.9 (2.7) |
4.8 (3.0) |
0.12 |
|
Cyclophosphamidea |
20 mg/kg |
44.3* (3.1) |
80.8** (11.6) |
2.02 |
Female data |
||||
Vehicle |
0 |
61.2 (4.9) |
8.8 (2.7) |
0.22 |
Test item |
1500 ppm |
60.3 (6.8) |
9.2 (1.8) |
0.23 |
4500 ppm |
68.7 (3.7) |
6.2 (3.7) |
0.16 |
|
15000 ppm |
63.0 (5.6) |
7.0 (1.4) |
0.18 |
|
Cyclophosphamidea |
20 mg/kg |
44.1** (2.6) |
64.4** (12.6) |
1.61 |
Vehicle: Basal diet
PCE: Polychromatic erythrocytes
MPCE: Number of micronucleated polychromatic erythrocytes observed per 4000 polychromatic erythrocytes examined
SD: Standard deviation
a Positive control slides from HLS1035
# Occasional apparent errors of ± 1% may occur due to rounding of values for presentation in the table.
Results of statistical analysis using the appropriate nonparametric method of analysis based on permutation (one-sided probabilities):
*p< 0.05 (significant)
**p< 0.01 (significant)
otherwise p> 0.05 (not significant)
Applicant's summary and conclusion
- Conclusions:
- Under the test conditions, test item did not show any evidence of causing an increase in the induction of micronucleated polychromatic erythrocytes or bone marrow cell toxicity in male or female Crl:CD(SD) rats.
- Executive summary:
In micronucleus test conducted according to OECD 474 guideline and in compliance with GLP, induction of micronuclei by test item in bone marrow cells of male and female Crl:CD(SD) rats was assessed.
Bone marrow smears were obtained from 5 male and 5 female animals in the vehicle control group and in each of the test substance groups at the appropriate time. At least one smear from each animal was examined for the presence of micronuclei in 4000 polychromatic erythrocytes. The proportion of polychromatic erythrocytes was assessed by examination of at least 1000 erythrocytes from each animal. A record of the incidence of micronucleated normochromatic erythrocytes was also kept.
No statistically significant increases in the frequency of micronucleated polychromatic erythrocytes and no statistically significant decreases in the proportion of polychromatic erythrocytes were observed in Crl:CD(SD) rats at any dose level, compared to vehicle control values. The coded positive control slides prepared from study HLS1035 demonstrated the ability of the scorer to detect increases in micronucleated polychromatic erythrocytes.
Under the test conditions, test item did not show any evidence of causing an increase in the induction of micronucleated polychromatic erythrocytes or bone marrow cell toxicity in male or female rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.